Herman Miller (MLHR) with an increase of 15.2%. Reported a quarterly EPS of $1.24, $0.98 higher than the analyst expectation of $0.26. Returns for the quarter arrived at $626.8 million in opposition to the consensus expectation of $524.83 million. 

Cardlytics, Inc (CDLX) with a decrease of 5%. Plans to offer, subject to market conditions and other details, $200 million principal amount of convertible senior notes due for 2025 in a private arrangement.

First Solar, Inc. (FSLR) with a decrease of 3.5%. Revealed as the starting point of an underwritten registered secondary offering of 8,649,074 shares, or roughly 8.2%, of the Corporation’s excellent common stock.

Moderna, Inc (MRNA) with an increase of 1.7%. Moderna and Vertex Pharmaceuticals Incorporated (VRTX) revealed today a fresh strategic research partnership and licensing agreement targeted at the discovery and development of lipid nanoparticles and mRNAs for the distribution of gene-editing therapies for the treatment of cystic fibrosis (CF).